Fluorescence Discrimination of Pharmacological Effects on the Na⁺-Ca²⁺ Exchanger and Sarco-Endoplasmic Reticulum Ca²⁺-ATPase in Mouse Ventricular Cardiomyocytes

  • Namekata Iyuki
    Department of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Odaka Ryosuke
    Department of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Hamazaki Shunsuke
    Department of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Nisaka Hina
    Department of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Hamaguchi Shogo
    Department of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Tanaka Hikaru
    Department of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University

書誌事項

タイトル別名
  • Fluorescence Discrimination of Pharmacological Effects on the Na<sup>+</sup>–Ca<sup>2+</sup> Exchanger and Sarco-Endoplasmic Reticulum Ca<sup>2+</sup>-ATPase in Mouse Ventricular Cardiomyocytes

この論文をさがす

抄録

<p>We developed a method to evaluate the activity of the Na+–Ca2+ exchanger (NCX) and sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) with fluorescence microscopy in mouse ventricular cardiomyocytes. In non-beating ventricular cardiomyocytes, α-adrenoceptor stimulation by phenylephrine caused a decrease in the cytoplasmic Ca2+ concentration, which was inhibited by SEA0400, an NCX inhibitor, but not cyclopiazonic acid, a SERCA inhibitor. β-Adrenoceptor stimulation by isoprenaline caused a decrease in the cytoplasmic Ca2+ concentration, which was inhibited by cyclopiazonic acid but not SEA0400. Ellagic acid, a phenolic phytochemical, also decreased the basal Ca2+ concentration, which was inhibited by cyclopiazonic acid, but not SEA0400. Thus, this method using fluorescent microscopy and specific inhibitors would be useful for the evaluation of pharmacological agents acting on NCX and SERCA.</p>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (11)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ